Use of oral contraceptives in the treatment of women with polycystic ovary syndrome

Author： Stovall Dale W   Menke Marie   Springel Edward   Jarvis Amber   Karjane Nicole  

Publisher： Informa Healthcare

ISSN： 1747-4108

Source： Expert Review of Obstretrics and Gynecology, Vol.2, Iss.3, 2007-05, pp. : 347-355

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy of an oral contraceptive containing drospirenone in the treatment of women with polycystic ovary syndrome

By Pehlivanov B.   Mitkov M.  

The European Journal of Contraception and Reproductive Health Care, Vol. 12, Iss. 1, 2007-01 ,pp. : 30-35

Informa Healthcare

Access to resources Recommend Favorite

Androgen and lipid profiles in adolescents with polycystic ovary syndrome who were treated with two forms of combined oral contraceptives

By Mastorakos G.   Koliopoulos C.   Creatsas G.  

Fertility and Sterility, Vol. 77, Iss. 5, 2002-05 ,pp. : 919-927

Elsevier

Access to resources Recommend Favorite

Role of the follistatin gene in women with polycystic ovary syndrome

By Calvo R.M.   Villuendas G.   Sancho J.   San Millan J.L.   Escobar-Morreale H.F.  

Fertility and Sterility, Vol. 75, Iss. 5, 2001-05 ,pp. : 1020-1023

Elsevier

Access to resources Recommend Favorite

Apolipoprotein E alleles in women with polycystic ovary syndrome

By Heinonen S.   Korhonen S.   Hippelainen M.   Hiltunen M.   Mannermaa A.   Saarikoski S.  

Fertility and Sterility, Vol. 75, Iss. 5, 2001-05 ,pp. : 878-880

Elsevier

Access to resources Recommend Favorite

Familial associations in women with polycystic ovary syndrome

By Atiomo W.U.   El-Mahdi E.   Hardiman P.  

Fertility and Sterility, Vol. 80, Iss. 1, 2003-07 ,pp. : 143-145

Elsevier

Access to resources Recommend Favorite